Motion Management for Lung Cancer Radiation
This study is testing a new way to track lung tumors and nearby organs during radiation treatment for non-small cell lung cancer (NSCLC). It uses a special MRI scan (4D CT Simulation and 4S MRI with surface monitoring) before radiation and X-ray images (fluoroscopy) during daily treatment. The goal is to see if this method can more accurately pinpoint the tumor and healthy organs compared to current standard methods. This study is for adults aged 18 and older with Stage II-IIIb NSCLC who are having radiation therapy. The study is currently unclear on its recruitment status.
- Study design
- This interventional study plans to enroll 44 participants. It is not specified if it is randomized or blinded.
- What's involved
- Participants will have a 4D CT Simulation and 4S MRI scan with surface monitoring before radiation, followed by fluoroscopy and additional surface monitoring during daily radiation.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome will be measured at 3 years after the intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
GCC 2546- Motion Management
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Amit Sawant, PhD · PRINCIPAL_INVESTIGATOR · University of Maryland, Baltimore
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- To investigate if time-resolved, multicycle volumetric motion modeling and monitoring gives improved spatiotemporal localization of the tumor target and OARs compared to current standard-of-care 4DCT-based motion modeling and monitoring3 years